These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9185508)

  • 1. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.
    Zhang SH; Reddick RL; Avdievich E; Surles LK; Jones RG; Reynolds JB; Quarfordt SH; Maeda N
    J Clin Invest; 1997 Jun; 99(12):2858-66. PubMed ID: 9185508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.
    Moghadasian MH; McManus BM; Godin DV; Rodrigues B; Frohlich JJ
    Circulation; 1999 Apr; 99(13):1733-9. PubMed ID: 10190884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution.
    van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M
    Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
    Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
    Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
    Guo X; Wang L; Xia X; Wang P; Li X
    Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.
    Davis HR; Compton DS; Hoos L; Tetzloff G
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2032-8. PubMed ID: 11742881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice.
    Macdonald DL; Terry TL; Agellon LB; Nation PN; Francis GA
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1583-8. PubMed ID: 12855483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI.
    Crauwels HM; Van Hove CE; Holvoet P; Herman AG; Bult H
    Cardiovasc Res; 2003 Jul; 59(1):189-99. PubMed ID: 12829190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
    Boisvert WA; Black AS; Curtiss LK
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary phytosterols reduce probucol-induced atherogenesis in apo E-KO mice.
    Moghadasian MH
    Atherosclerosis; 2006 Sep; 188(1):28-34. PubMed ID: 16325824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
    Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
    J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice.
    Lukic T; Wasan KM; Zamfir D; Moghadasian MH; Pritchard PH
    Metabolism; 2003 Apr; 52(4):425-31. PubMed ID: 12701053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.